RECOMBINANT INTERFERON ALFA-2C VERSUS POLYCHEMOTHERAPY (VMCP) FOR TREATMENT OF MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED TRIAL

被引:48
作者
LUDWIG, H [1 ]
CORTELEZZI, A [1 ]
SCHEITHAUER, W [1 ]
VANCAMP, BGK [1 ]
KUZMITS, R [1 ]
FILLET, G [1 ]
PEETERMANS, M [1 ]
POLLI, E [1 ]
FLENER, R [1 ]
机构
[1] VIENNA UNIV,DEPT MED 2,A-1090 VIENNA,AUSTRIA
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1986年 / 22卷 / 09期
关键词
D O I
10.1016/0277-5379(86)90015-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1111 / 1116
页数:6
相关论文
共 18 条
[1]  
AAPRO MS, 1983, CANCER CHEMOTH PHARM, V10, P161
[2]  
AHRE A, 1984, CANCER TREAT REP, V68, P1331
[3]  
ALEXANIAN R, 1982, CLIN HAEMATOLOGY, P211
[4]   INTERFERON THERAPY IN MULTIPLE-MYELOMA - FAILURE OF HUMAN FIBROBLAST INTERFERON ADMINISTRATION TO AFFECT THE COURSE OF LIGHT CHAIN DISEASE [J].
BILLIAU, A ;
BLOEMMEN, J ;
BOGAERTS, M ;
CLAEYS, H ;
VANDAMME, J ;
DELEY, M ;
DESOMER, P ;
DROCHMANS, A ;
HEREMANS, H ;
KRIEL, A ;
SCHETZ, J ;
TRICOT, G ;
VERMYLEN, C ;
VERWILGHEN, R ;
WAER, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (08) :875-882
[5]  
CLARK RH, 1984, J BIOL RESP MODIF, V3, P613
[6]  
COOPER MR, 1985, P AM SOC CLIN ONCOL, V4, P216
[7]   PHASE-II STUDY OF RECOMBINANT ALPHA-2 INTERFERON IN RESISTANT MULTIPLE-MYELOMA [J].
COSTANZI, JJ ;
COOPER, MR ;
SCARFFE, JH ;
OZER, H ;
GRUBBS, SS ;
FERRARESI, RW ;
POLLARD, RB ;
SPIEGEL, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) :654-659
[8]  
EINHORN S, 1978, HUMAN INTERFERON PRO, P159
[9]   CLINICAL AND IMMUNOLOGICAL STUDIES OF HUMAN FIBROBLAST INTERFERON [J].
EZAKI, K ;
OGAWA, M ;
OKABE, K ;
ABE, K ;
INOUE, K ;
HORIKOSHI, N ;
INAGAKI, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (01) :47-55
[10]   LEUKOCYTE INTERFERON-INDUCED TUMOR-REGRESSION IN HUMAN METASTATIC BREAST-CANCER, MULTIPLE-MYELOMA, AND MALIGNANT-LYMPHOMA [J].
GUTTERMAN, JU ;
BLUMENSCHEIN, GR ;
ALEXANIAN, R ;
YAP, HY ;
BUZDAR, AU ;
CABANILLAS, F ;
HORTOBAGYI, GN ;
HERSH, EM ;
RASMUSSEN, SL ;
HARMON, M ;
KRAMER, M ;
PESTKA, S .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (03) :399-406